Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Citations Report

Pharmaceutical Regulatory Affairs: Open Access : Citations & Metrics Report

Articles published in Pharmaceutical Regulatory Affairs: Open Access have been cited by esteemed scholars and scientists all around the world.

Pharmaceutical Regulatory Affairs: Open Access has got h-index 12, which means every article in Pharmaceutical Regulatory Affairs: Open Access has got 12 average citations.

Following are the list of articles that have cited the articles published in Pharmaceutical Regulatory Affairs: Open Access.

  2022 2021 2020 2019 2018

Year wise published articles

60 60 8 15 18

Year wise citations received

49 62 76 75 53
Journal total citations count 533
Journal impact factor 2.15
Journal 5 years impact factor 2.86
Journal cite score 2.85
Journal h-index 12
Journal h-index since 2018 9
Important citations

Kavyashree, Hiremath P., F. Fernandes, and P. Muragundi. "A cross-sectional study of USFDA warning letters issued for cGMP violations pertaining to medical devices." J Appl Pharm Sci 10, no. 05 (2020): 049-053.

Pohl, Pawe?, Piotr Jamróz, Anna Dzimitrowicz, and Krzysztof Gr?da. "Analiza pierwiastkowa leków i farmaceutyków." XII SEMINARIUM NAUKOWE: 10.

Aghayere, Godfrey E., and Patrick O. Igbinaduwa. "Assessment of selected heavy metals in some anti-diarrhea pharmaceutical formulations containing kaolin available in pharmacies in Benin City, Nigeria." West African Journal of Pharmacy 32, no. 1 (2021): 165-173.

Mautsoe, Relebohile, Taelo Noko, and Oriel Hlokoane. "Microbial and Heavy Metal Contaminants in Herbal Preparations Sold in Maseru, Lesotho." International Journal of Pharmacy and Chemistry 7, no. 4 (2021): 71.

Beltifa, Asma, Sana Alibi, Vincenzo Lo Turco, Hedi Ben Mansour, and Giuseppa Di Bella. "Identification and quantification of plasticizers, bisphenol, and environmental toxic mineral elements residues in medicines from Tunisian markets." Environmental Science and Pollution Research (2021): 1-9.

Bokov, D. O., O. G. Potanina, A. V. Nikulin, V. M. Shchukin, V. A. Orlova, G. B. Bagirova, S. D. Kakhramanova et al. "Modern approaches to the analysis of kelp (Laminaria sp.) as pharmacopoeial herbal drugs and food products." Pharmacognosy Journal 12, no. 4 (2020).

Carpentier, Florian, François-Xavier Felpin, Françoise Zammattio, and Erwan Le Grognec. "Synthesis of 5-Substituted 1 H-Tetrazoles from Nitriles by Continuous Flow: Application to the Synthesis of Valsartan." Organic Process Research & Development 24, no. 5 (2020): 752-761.

Maithani, M., R. Raturi, P. Sharma, V. Gupta, and P. Bansal. "Elemental impurities in pharmaceutical products adding fuel to the fire." Regulatory Toxicology and Pharmacology 108 (2019): 104435.

Chrétien, Jean?Mathieu, Gaelle Kerric, Françoise Zammattio, Nicolas Galland, Michael Paris, Jean?Paul Quintard, and Erwan Le Grognec. "Tin?Catalyzed Synthesis of 5?Substituted 1H?Tetrazoles from Nitriles: Homogeneous and Heterogeneous Procedures." Advanced Synthesis & Catalysis 361, no. 4 (2019): 747-757.

Pohl, Pawel, Aleksandra Bielawska-Pohl, Anna Dzimitrowicz, Piotr Jamroz, and Maja Welna. "Impact and practicability of recently introduced requirements on elemental impurities." TrAC Trends in Analytical Chemistry 101 (2018): 43-55.

Ansi, V. A., and N. K. Renuka. "Table sugar derived Carbon dot–a naked eye sensor for toxic Pb2+ ions." Sensors and Actuators B: Chemical 264 (2018): 67-75.

Hole, Glenn, Anastasia S. Hole, and Ian McFalone-Shaw. "Digitalization in pharmaceutical industry: What to focus on under the digital implementation process?." International Journal of Pharmaceutics: X 3 (2021): 100095.

Kumar, Nirmal, and Ajeya Jha. "Application of principles of supply chain management to the pharmaceutical good transportation practices." International Journal of Pharmaceutical and Healthcare Marketing (2019).

Raveendrashenoy, Rujitha Thammanathuparambil. "Role of Patents in Biosimilar Drug Development and Public Interest." J. Sci. Res. 9, no. 2s (2020): s37-s47.

Natarajan, Aparna, Nikita Mehra, and Thangarajan Rajkumar. "Economic perspective of cancer treatment in India." Medical Oncology 37, no. 11 (2020): 1-7.

SINDKHEDKAR, MILIND, SANDEEP JAGTAP, CHIRAG SHAH, and VENKATA P. PALLE. "Pharmaceutical Research in India: Current Status and Opportunities." In Proc Indian Natn Sci Acad, vol. 86, no. 2, pp. 1015-1022. 2020.

Majumder, Srinanda, and Madhumita Nandi. "Biologics to Biosimilars: Bombshell to Boon!." The Child and Newborn: 16.

Pradhan, Gauri, J. M. Sneha, Babasaheb P. Sonwane, B. Santhakumari, Alka Rao, and Mahesh J. Kulkarni. "Multiple-parallel-protease digestion coupled with high-resolution mass spectrometry: An approach towards comprehensive peptide mapping of therapeutic mAbs." Journal of proteomics 232 (2021): 104053.

Esteban, Efraín, Rosa-Helena Bustos, Julio-César García, and Edwin Jáuregui. "Biosimilars: an approach to some current worldwide regulation frameworks." Current clinical pharmacology 14, no. 1 (2019): 16-40.

Rahalkar, Hasumati, Hacer Coskun Cetintas, and Sam Salek. "Quality, non-clinical and clinical considerations for biosimilar monoclonal antibody development: EU, WHO, USA, Canada, and BRICS-TM regulatory guidelines." Frontiers in pharmacology 9 (2018): 1079.

Relevant Topics

Google Scholar citation report
Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

arrow_upward arrow_upward